The introduction of a special medication, designed to help people with cystic fibrosis, looks to have taken another step forward.

Amongst those calling for the medication, Orkambi, is Dwygyfylchi mother Kim Roberts who's two and half year old daughter Ivy has the illness.

Mrs Roberts has thrown her support behind a petition to the UK Government which has now been signed by more than 113,000 people.

Now the petition is set to be presented to 10 Downing Street today with a protest also prepared to take place at Westminster.

She said: "It would be our dream come true forever more when Orkambi becomes available on the NHS.

"This drug will keep Ivy stable, it will halt her cystic fibrosis allow her to do all the things we’re scared she won’t be able to achieve due to the disease."

In 2016 the National Institute for Health and Care Excellence (NICE) concluded that it was unable to recommend the use of Orkambi as "its considerable cost was not in balance with its likely benefits and it could therefore not be considered a cost-effective use of NHS resources".

However Vertex, the company behind the medication, say they have been working closely with stakeholders across the UK, including key executive agencies of Government in Wales, and believe they have come up with a new proposal to make Orkambi available on the NHS.

A Vertex spokesperson said: "We share the CF community’s sense of urgency on access to new Vertex medicines and we are committed to working with the NHS to find a sustainable funding solution.

"That is why we have proposed to the Government a bold new portfolio approach that could make our medicines available to patients as soon as possible. It provides budget certainty and value to the NHS − and offers fair and equal access for CF patients to precision medicines that are tailored to specific genetic mutations.

"At Vertex we are developing medicines to treat 90 per cent of CF patients who will one day be eligible for treatment able to treat the underlying cause of the disease.

“We believe that our approach is a first for England, and a first for the UK. We have already demonstrated it works in other countries − and offers CF patients who could benefit from access to Orkambi."

The push will take another step forward with members of parliament to debate Orkambi in a Petition Committee meeting on March 19.

The committee has scheduled a debate in Westminster Hall on the motion that “This House has considered e-petition 209455 relating to access to the drug Orkambi for people with Cystic Fibrosis.”

The Government said it welcomed the dialogue between Vertex and NHS England to agree a deal that would make Orkambi available to patients.